expert roundtables

Overcoming the Immunosuppressive Tumor Microenvironment in Metastatic Pancreatic Cancer
Oncology

Overcoming the Immunosuppressive Tumor Microenvironment in Metastatic Pancreatic Cancer

expert roundtables
By Alok Khorana, MD; Michael Morse, MD, MHS, FACP; Thomas A. Abrams, MD
Minimal Residual Disease Negativity in Chronic Lymphocytic Leukemia
Oncology

Minimal Residual Disease Negativity in Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Oncology

Initiating Novel Agents Versus Chemoimmunotherapy in the Front-line Setting

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Unmet Treatment Needs Span the Natural History of Rheumatoid Arthritis
Rheumatology

Unmet Treatment Needs Span the Natural History of Rheumatoid Arthritis

expert roundtables
By John R. P. Tesser, MD; Jonathan Kay, MD; Leonard H. Calabrese, DO; Vibeke Strand, MD, MACR, FACP
Immune Dysfunction and Infection Risk in Chronic Lymphocytic Leukemia
Oncology

Immune Dysfunction and Infection Risk in Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Load More